Despite stronger competitors, Saxenda remains a valid treatment option
(2020) developed a rapid method to generate midbrain-like structures (simBOs) using Shh and FGF8
Always seek advice of physicians, nurse practitioners, registered dietitians, or other appropriate healthcare professionals with any questions regarding medical conditions, prescription medications, treatment options, weight management approaches, or health decisions
People with a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2, pancreatitis, or severe gastrointestinal conditions should avoid GLP1 weight-loss drugs unless specifically advised by their physician
Eur Arch Otorhinolaryngol 273(12):46294635